Embla Medical hf (EMBLA.CO) has a MoatMap StockRank of 41/100 based on Quality (57/100), Value (29/100), and Momentum (42/100) factor scores. The current signal is HOLD. Embla Medical (formerly Ossur) is a high-quality prosthetics business, but it currently lacks a strong macro inflection tailwind or alignment with our five core themes to justify a concentrated position.
Embla Medical hf (formerly Össur hf) is a global leader in non-invasive orthopaedics, specializing in the development and manufacture of advanced prosthetics, bracing, and support solutions. The company holds a strong market position, particularly in bionic prosthetic technologies that utilize microprocessors to mimic natural limb movement. Embla Medical benefits from high barriers to entry due to extensive patent protection, clinical validation requirements, and established relationships with prosthetic clinics worldwide.
| Price | $4.24 |
| Market Cap | $1.8B |
| P/E (TTM) | 21.12 |
| P/E (Forward) | 16.13 |
| Price/Book | 2.03 |
| Return on Equity | 10.1% |
| Return on Invested Capital | 9.0% |
| Debt/Equity | 61.13 |
| Gross Margin | 62.0% |
| Operating Margin | 9.7% |
| Revenue Growth | 14.6% |
| Free Cash Flow | $2M |
Embla Medical hf operates in the Medical Devices industry, part of the Healthcare sector (Iceland).